Originally published by our sister publication Infectious Disease Special Edition
By Marie Rosenthal, MS
The CDC’s Advisory Committee on Immunization Practices recommended adding the recently approved meningococcal groups A, B, C, W and Y vaccine (MenABCWY; Penbraya, Pfizer) to the U.S. vaccination schedule.
MenABCWY is the first and only pentavalent vaccine that provides coverage against the most common serogroups causing meningococcal disease in people 10 through 25 years of age. The FDA